Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Marcenaro

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reviews|September 29, 2024
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancerFederico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
Cell Death Discovery|March 28, 2026
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancerSimone Ielpo, Francesca Barberini, Alice Gaiba, et al.
Haematologica|April 28, 2018
The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.
Frontiers in Immunology|June 29, 2026
HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8<sup>+</sup> tumor-infiltrating lymphocytesGiulia Querzoli, Giuseppe Bogina, Marcella Marconi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2021
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatmentTania Buttiron Webber, Nicoletta Provinciali, Marco Musso, et al.
Nature Communications|June 30, 2022
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editingSumin Jo, Shipra Das, Alan Williams, et al.
Frontiers in Immunology|July 3, 2025
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1<sup>+</sup> NK cells in microsatellite instability tumorsValentina Obino, Chiara Giordano, Simona Carlomagno, et al.
Cell Reports|October 23, 2021
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functionsValentina Cazzetta, Elena Bruni, Sara Terzoli, et al.
JCI Insight|May 18, 2021
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCTElisa Zaghi, Michela Calvi, Simone Puccio, et al.
Cancer Immunology Research|April 4, 2019
Accumulation of Circulating CCR7<sup>+</sup> Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic PathwayCostanza Maria Cristiani, Alice Turdo, Valeria Ventura, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reviews|September 29, 2024
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancerFederico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
Cell Death Discovery|March 28, 2026
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancerSimone Ielpo, Francesca Barberini, Alice Gaiba, et al.
Haematologica|April 28, 2018
The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.
Frontiers in Immunology|June 29, 2026
HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8<sup>+</sup> tumor-infiltrating lymphocytesGiulia Querzoli, Giuseppe Bogina, Marcella Marconi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2021
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatmentTania Buttiron Webber, Nicoletta Provinciali, Marco Musso, et al.
Nature Communications|June 30, 2022
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editingSumin Jo, Shipra Das, Alan Williams, et al.
Frontiers in Immunology|July 3, 2025
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1<sup>+</sup> NK cells in microsatellite instability tumorsValentina Obino, Chiara Giordano, Simona Carlomagno, et al.
Cell Reports|October 23, 2021
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functionsValentina Cazzetta, Elena Bruni, Sara Terzoli, et al.
JCI Insight|May 18, 2021
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCTElisa Zaghi, Michela Calvi, Simone Puccio, et al.
Cancer Immunology Research|April 4, 2019
Accumulation of Circulating CCR7<sup>+</sup> Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic PathwayCostanza Maria Cristiani, Alice Turdo, Valeria Ventura, et al.
Pageof 11